Belgium: Food and Drugs Law

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

Belgian Pharma Law Summer Blog Series (Part 1): The Act Of 30 May 2026 Containing Various Provisions On Medicinal And Health Products

Belgium introduces significant reforms to pharmaceutical law through the Act of 30 May 2026, addressing critical medicine shortages through enhanced export controls and stock allocation measures. The legislation also modernizes the Federal Agency for Medicines and Health Products' operational framework and adapts clinical trial regulations to support decentralized research models.

Belgium Healthcare

A

Altius

Life Sciences Patents Monthly Roundup—May 2026

This month, at the Unified Patent Court (UPC), the Düsseldorf Local Division’s dismissal of Align Technology’s provisional measures application against Angelalign reinforces the applicant’s evidential...

European Union IP

AO

A&O Shearman

New EU Sample Retention Rules Coming Up For Veterinary Medicines Repackaged For Parallel Trade

The Veterinary Medicinal Products Regulation (EU) 2019/6 has applied in the EU since 28 January 2022, replacing Directive 2001/82/EC. The new rules on good manufacturing practice (GMP) will in turn...

European Union Healthcare

A

Altius

EU Pharma Package: Advertising Compromise Proposal

In our ninth alert in this EU Pharma Package Series, we discussed the proposals of the Commission, Council, and Parliament with respect to advertising of medicinal products.

Belgium Healthcare

CM

Crowell & Moring LLP

The New EU "Pharma Package": Access Conditionalities And Shortage Measures Compromise Proposal

Belgium Healthcare

CM

Crowell & Moring LLP

EU Pharma Package: The “Bolar” Exemption Compromise Proposal

CM

Crowell & Moring LLP

EU Pharma Package: Global (Orphan) Marketing Authorization Compromise Proposal

European Union Healthcare

CM

Crowell & Moring LLP

The EU Pharma Package: The Transferable Exclusivity Voucher Compromise Proposal

European Union Healthcare

CM

Crowell & Moring LLP

The EU Pharma Package: Formal Adoption In Sight

European Union Healthcare

CM

Crowell & Moring LLP

EU Reaches Pharma Package Deal: Key Changes At A Glance

Belgium Healthcare

A

Altius

Plastic Food Contact Materials: Declaration Of Compliance Soon To Reflect Compliance With New Purity Requirements

European Union Environment

MB

Mayer Brown

Food Hygiene For Fish: EU General Court Requires Scientific Basis To "Clarify" The Law

Belgium Healthcare

A

Altius

European Commission Publishes New Variation Guidelines For Medicines

European Union Healthcare

AP

Arnold & Porter

The New EU "Pharma Package": Interplay With The Critical Medicines Act And Other Shortage Initiatives

European Union Healthcare

CM

Crowell & Moring LLP

Managing Restructurings In APAC: Legal, Practical And People Considerations

Worldwide Employment

IL

Ius Laboris

Extreme Heat At Work: What Practical Steps Should Employers Take?

Belgium Employment

IL

Ius Laboris

Youth In The Digital Age: Challenges And Opportunities

Belgium Employment

IL

Ius Laboris

Vivendi/Lagardère: EU General Court Dismisses Human Rights Objections And Confirms Commission’s Broad Information-Gathering Powers In Merger Investigations

Belgium Anti-trust

M

Macfarlanes LLP

The EU's Tax Simplification Package: Practical Implications And Key Considerations

European Union Tax

AO

A&O Shearman

The New EU "Pharma Package": Access Conditionalities And Shortage Measures – A Comparison Of Commission/Parliament/Council Positions

In this seventh alert in our weekly series on the Pharma Package, we will discuss the increasing focus on shortages of medicinal products in the EU and the prevention...

Belgium Healthcare

CM

Crowell & Moring LLP

Two Kiwis Per Day Chase Constipation Away – European Commission Approves Health Claim For Fruit

The European Commission has authorised a new food health claim recognising the digestive health benefits of green kiwifruit. The claim—"Consumption of green kiwifruit contributes...

Belgium Healthcare

A

Altius

The New EU "Pharma Package": The "Bolar" Exemption – A Comparison Of Commission/Parliament/Council Positions

In this sixth alert in our weekly series on the EU Pharma Package, we focus on the proposals of the European Commission, European Parliament and Council of the EU for another topic with a highly debated scope and with diverging interpretations across EU Member States: the "Bolar" exemption.

European Union IP

CM

Crowell & Moring LLP

Updates To The EU Pharmacovigilance Rules: Key Takeaways For Marketing Authorisation Holders

On 22 July 2025, the European Commission adopted Implementing Regulation (EU) 2025/1466 ("Regulation"), updating the EU pharmacovigilance (or "PV") rules by way of amendments...

European Union Healthcare

AP

Arnold & Porter

The New EU "Pharma Package": Global (Orphan) Marketing Authorization

European Union Healthcare

CM

Crowell & Moring LLP

The New EU "Pharma Package": The Debate On Fiscal Import In The Supply Chain

European Union Healthcare

CM

Crowell & Moring LLP

The New EU "Pharma Package": The Transferable Exclusivity Voucher—A Comparison Of Commission/Parliament/Council Positions

European Union Healthcare

CM

Crowell & Moring LLP

The New EU "Pharma Package": Regulatory Data Protection – A Comparison Of Commission/Parliament/Council Positions

European Union Privacy

CM

Crowell & Moring LLP

European Commission Consultation Shapes High-risk AI Classification For Life Sciences In The EU

European Union Healthcare

OC

Osborne Clarke

EU Guidance Details How Technical And Clinical Standards Converge For AI In Medtech

European Union Healthcare

OC

Osborne Clarke

The New EU "Pharma Package": Preparing For The Trilogues

European Union Healthcare

CM

Crowell & Moring LLP

Council Position On EU Pharma Package Adopted

European Union Healthcare

AO

A&O Shearman

EU Geopolitical Risk Update - Key Policy & Regulatory Developments No. 121

European Union Technology

JD

Jones Day

EU Geopolitical Risk Update - Key Policy & Regulatory Developments No. 119

European Union Technology

JD

Jones Day

The New EU "Pharma Package": Preparing For The Trilogues

On June 4, 2025, after nearly two years of intense debate and negotiation between the 27 EU Member States, the Council of the European Union adopted its position on the proposed overhaul of the EU general pharmaceutical legislative framework known as the new Pharma Package.

European Union Healthcare

CM

Crowell & Moring LLP

Council Position On EU Pharma Package Adopted

On 4 June, the Council of the European Union (Council) adopted its negotiation position on the proposals for a new regulation and directive that make up the so-called ‘pharma package'.

European Union Healthcare

AO

A&O Shearman

EU Geopolitical Risk Update - Key Policy & Regulatory Developments No. 121

This regular alert covers key policy and regulatory developments related to EU geopolitical risks, including in particular, economic security...

European Union Technology

JD

Jones Day

EU Geopolitical Risk Update - Key Policy & Regulatory Developments No. 119

This regular alert covers key policy and regulatory developments related to EU geopolitical risks, including in particular, economic security, Russia's war against Ukraine, health threats, and cyber threats.

European Union Technology

JD

Jones Day

Brussels Enterprise Court Clarifies Requirements For SPC Manufacturing Waiver

Belgium Healthcare

AO

A&O Shearman

Preparing For The EU's New Approach To Critical Medicines And Medicine Shortages: A New 'Critical Medicines Act'?

The EU legal and policy framework regarding critical medicines and medicine shortages is rapidly changing. In the past 12 months alone, there have been numerous developments...

European Union Healthcare

CM

Crowell & Moring LLP

Brussels Court Of Appeal Prohibits The Rebranding Of A Generic Pharmaceutical Into The Originator Reference Product In The Framework Of Parallel Import

The Judgment of the Brussels Court of Appeal is the latest development in the saga in Belgium where a Belgian parallel importer, PI Pharma NV, imported a generic Sandoz product from the Netherlands...

Belgium Media & IT

CM

Crowell & Moring LLP

Future Foods Update | May 2024

The Food Standards and Information Focus Group (FSIFG) has prepared draft guidance on how plant-based dairy companies should describe their products...

Worldwide Healthcare

OC

Osborne Clarke

HFSS Newsletter | May 2024

Evolving regulatory approaches taken by France, Germany and Spain and elsewhere in the UK means businesses should keep a watching brief on the changing rules.

Worldwide Healthcare

OC

Osborne Clarke

EU Court Of Justice Interprets Import Ban On Chinese Animal Products: Fish Oil For Feed Is Not An Exempted "Fishery Product"

European Union Healthcare

A

Altius

"Shrinkflation": A New Obligation For Distributors Regarding The Display Of Their Products

Belgium Healthcare

OC

Osborne Clarke

CJEU Balances Strict Obligations For Wholesalers Of Medicines With Proportional Penalties

European Union Healthcare

A

Altius

WEBINAR VIDEO | Belgium's Medicines Reimbursement Reform (Video)

Belgium Healthcare

A

Altius

HFSS Newsletter | February 2024

Worldwide Media & IT

OC

Osborne Clarke

EU Pharmaceutical Reforms To Overhaul Marketing And Manufacturing Rules

European Union Healthcare

OC

Osborne Clarke

Food Law | UK Regulatory Outlook January 2024

Belgium Healthcare

OC

Osborne Clarke

Three Changes In Belgian Food Law In 2023

Belgium Healthcare

A

Altius

Two Changes In Belgian Food Law In 2023

Belgium Healthcare

A

Altius

The 5 Major Changes In Belgian Pharma Law Of 2023

Belgium Healthcare

A

Altius

EU Adopts Restriction Of Intentionally Added Microplastics

European Union Healthcare

CL

Cooley LLP

Authority Imposes A EUR 2.78 Million Fine On Novartis For Disparaging Its Competitor's Products

Belgium Anti-trust

BB

Bird & Bird

European Medicines Agency Publishes Q&A On Clinical Trial Data Transparency

European Union Healthcare

CL

Cooley LLP

Early Access To Pharmaceutical Products In Major European Markets

European Union Healthcare

HL

Hogan Lovells

EMA Guidance On Comparability Exercise For ATMPs

Belgium Healthcare

AP

Arnold & Porter

See more

Latest Videos

See more

Life Sciences Outlook 2026 - Mergers And Acquisitions (Video)

AC

Arthur Cox

Second Medical Use Claims At The UPC: What Are The Infringement Prerequisites And Legal Standards? (Video)

BP

Bardehle Pagenberg

Madrid video updates: Estrategia Europea contra los medicamentos falsificados

HS

Herbert Smith Freehills Kramer LLP

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More